PASQUALI, SANDRO
 Distribuzione geografica
Continente #
NA - Nord America 5.970
EU - Europa 545
AS - Asia 472
AF - Africa 7
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 7.000
Nazione #
US - Stati Uniti d'America 5.960
CN - Cina 260
IT - Italia 189
SG - Singapore 167
DE - Germania 72
FI - Finlandia 72
GB - Regno Unito 59
UA - Ucraina 35
VN - Vietnam 30
SE - Svezia 28
FR - Francia 25
IE - Irlanda 25
NL - Olanda 17
RU - Federazione Russa 10
IN - India 9
BZ - Belize 5
CA - Canada 5
BR - Brasile 4
EG - Egitto 3
BE - Belgio 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
JP - Giappone 2
ZA - Sudafrica 2
AT - Austria 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BJ - Benin 1
BN - Brunei Darussalam 1
ES - Italia 1
EU - Europa 1
HU - Ungheria 1
ID - Indonesia 1
MD - Moldavia 1
PL - Polonia 1
RO - Romania 1
SC - Seychelles 1
TR - Turchia 1
Totale 7.000
Città #
Fairfield 1.090
Woodbridge 594
Houston 521
Ashburn 462
Ann Arbor 430
Chandler 395
Seattle 388
Cambridge 362
Wilmington 328
Santa Clara 131
Singapore 131
Jacksonville 123
San Diego 109
Boardman 108
Princeton 99
Roxbury 69
Beijing 68
Medford 66
Des Moines 57
Nanjing 45
Padova 36
Helsinki 33
Dong Ket 29
Dublin 22
Milan 19
Shenyang 18
Guangzhou 14
Washington 14
San Jose 12
London 10
Hebei 9
Nanchang 9
Jiaxing 8
Tianjin 8
Buffalo 7
Norwalk 7
Renton 7
Bergkamen 6
Cagliari 6
Jinan 6
New York 6
Ogden 6
Redwood City 6
Belize City 5
Changsha 5
Chicago 5
Falls Church 5
Fuzhou 5
Genoa 5
Glasgow 5
Saint Petersburg 5
Conegliano 4
Dallas 4
Dearborn 4
Detroit 4
Forlì 4
Indiana 4
Ivanovo 4
Kharkiv 4
Rome 4
Shanghai 4
Leiden 3
Liverpool 3
Paris 3
Parma 3
Saint Louis 3
Zhengzhou 3
Al Qahirah al Jadidah 2
Amsterdam 2
Borås 2
Brasília 2
Brussels 2
Bryanston 2
Chiswick 2
Cinisello Balsamo 2
Columbus 2
Fort Worth 2
Groningen 2
Hefei 2
Kilburn 2
Kunming 2
Leawood 2
Leeds 2
Los Angeles 2
Martellago 2
Ningbo 2
Nürnberg 2
Portici 2
Prescot 2
Southwark 2
São Paulo 2
Toronto 2
Absecon 1
Acton 1
Albuquerque 1
As Santah 1
Atlanta 1
Badia 1
Bandar Seri Begawan 1
Baotou 1
Totale 6.030
Nome #
Long-Term Results of Melphalan-Based Isolated Limb Perfusion With or Without Low-Dose TNF for In-Transit Melanoma Metastases. 166
Clinical Considerations on Sentinel Node Biopsy in Melanoma from an Italian Multicentric Study on 1,313 Patients (SOLISM-IMI) 163
Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study 156
Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer 148
Adherence to treatment guidelines for primary sarcomas affects patient survival: a side study of the European CONnective TIssue CAncer NETwork (CONTICANET). 146
Cytoreductive surgery alone or combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for pseudomyxoma peritonei 133
Actual false-negative rate prompts the routine use of ultrasound scan before and after sentinel node biopsy in melanoma 128
Sex and interleukin-6 are prognostic factors for autoimmune toxicity following treatment with anti-CTLA4 blockade 127
Videoscopic ilioinguinal lymphadenectomy for groin lymph node metastases from melanoma 125
Genetic susceptibility to bone and soft tissue sarcomas: A field synopsis and meta-analysis 123
Video endoscopic inguinal lymphadenectomy for lymph node metastasis from solid tumors 122
First- and second-line systemic treatments for metastatic and locally advanced soft tissue sarcomas in adults 118
Separate cavity margins excision as a complement to conservative breast cancer surgery 116
Interferon Alpha Adjuvant Therapy in Patients With High-Risk Melanoma: A Systematic Review and Meta-analysis 115
Pelvic lymph node status prediction in melanoma patients with inguinal lymph node metastasis 115
Management of metastatic retroperitoneal sarcoma: a consensus approach from the Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG) 113
Lymphadenectomy for melanoma: toward a videoscopic approach 112
Molecular markers of lymph node disease in melanoma 112
Systemic treatments for metastatic cutaneous melanoma 109
Measuring the quality of melanoma surgery - Highlighting issues with standardization and quality assurance of care in surgical oncology 108
Immune checkpoint inhibitors and targeted therapies for metastatic melanoma: A network meta-analysis 105
Maximizing the clinical usefulness of a nomogram to select patients candidate to sentinel node biopsy for cutaneous melanoma 104
N-Ratio: a Novel Independent Prognostic Factor for Patients with Stage-III Cutaneous Melanoma. 103
Risk-reducing medications for primary breast cancer: A network meta-analysis 102
Validation of the prognostic value of lymph node ratio in patients with cutaneous melanoma: A population-based study of 8,177 cases 101
Population-based cohort study of outcomes following cholecystectomy for benign gallbladder diseases 100
Histopathological characteristics of subsequent melanomas in patients with multiple primary melanomas. 96
False-Positivity in the Sentinel Lymph Nodes in Melanoma and Breast Cancer Reply 94
Oncomirs: From Tumor Biology to Molecularly Targeted Anticancer Strategies 93
Lymph-Node Ratio in Patients with Cutaneous Melanoma: A Multi-Institution Prognostic Study 92
The development and validation of a scoring tool to predict the operative duration of elective laparoscopic cholecystectomy 91
Population-based cohort study of variation in the use of emergency cholecystectomy for benign gallbladder diseases 90
Quality assurance in melanoma care: The EU-MELACARE study 90
Early (sentinel lymph node biopsy-guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases : personal Experience and Literature Meta-Analysis 88
Prognostic Role of Multiple Lymphatic Basin Drainage in Sentinel Lymph Node-Negative Trunk Melanoma Patients: A Multicenter Study from the Italian Melanoma Intergroup 88
The Anticancer Face of Interferon Alpha (IFN-Alpha): From Biology to Clinical Results, with a Focus on Melanoma 86
Interferon alpha for the adjuvant treatment of cutaneous melanoma. 86
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial 83
Tyrosine kinase inhibitor therapies for gastrointestinal stromal tumours 82
Sentinel Node Status Prediction by Four Statistical Models: Results From a Large Bi-Institutional Series (n=1132) 80
Cost-effectiveness of emergency versus delayed laparoscopic cholecystectomy for acute gallbladder pathology 80
Increasing the participation of medical students in surgical research: The Italian case and the role of research collaboratives 80
Factors Predictive of Nonsentinel Lymph Node Involvement and Clinical Outcome in Melanoma Patients With Metastatic Sentinel Lymph Node 79
High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial 78
Patient outcome after complete surgery for retroperitoneal sarcoma. 76
Survival After Neoadjuvant and Adjuvant Treatments Compared to Surgery Alone for Resectable Esophageal Carcinoma: A Network Meta-analysis 76
Lymphatic biomarkers in primary melanomas as predictors of regional lymph node metastasis and patient outcomes. 75
A pilot study reporting outcomes for melanoma patients of a minimal access ilio-inguinal dissection technique based on two incisions 75
Response to the letter: Students’ participation in collaborative research should be recognised 74
ItSURG: a challenge for surgical research in Italy 73
The number of excised lymph nodes is associated with survival of melanoma patients with lymph node metastasis 71
Number of excised lymph nodes as a quality assurance measure for lymphadenectomy in melanoma 71
Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study 70
Treatment challenges in and outside a network setting: Soft tissue sarcomas 70
Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancerCochrane Database of Systematic Reviews 70
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal sarcomatosis: long-term outcome from a single institution experience. 68
Risk-reducing medication for primary breast cancer: A network meta-analysis 68
Nonsentinel lymph node status in patients with cutaneous melanoma: results from a multi-institution prognostic study. 67
Effectiveness of Antibiotic Prophylaxis in Non-emergency Cholecystectomy Using Data from a Population-Based Cohort Study 66
The importance of adequate primary tumor excision margins and sentinel node biopsy in achieving optimal locoregional control for patients with thick primary melanomas 66
Targeted Therapy Database (TTD): a model to match patient's molecular profile with current knowledge on cancer biology 66
Contemporary controversies and perspectives in the staging and treatment of patients with lymph node metastasis from melanoma, especially with regards positive sentinel lymph node biopsy 65
TREATMENT CHALLENGES AND RISK STRATIFICATION FOR MELANOMA AND SARCOMAS 64
Surgeons' Opinions on Lymphadenectomy in Melanoma Patients with Positive Sentinel Nodes: A Worldwide Web-Based Survey. 62
Neoadjuvant chemotherapy in soft tissue sarcomas: Latest evidence and clinical implications 61
The natural history of epithelioid sarcoma. A retrospective multicentre case-series within the Italian Sarcoma Group 61
Correction to: Utilisation of an operative difficulty grading scale for laparoscopic cholecystectomy (Surgical Endoscopy, (2018), 10.1007/s00464-018-6281-2) 59
A Population-Based Cohort Study of Emergency Appendectomy Performed in England and New York State 59
Quality assurance in melanoma surgery: The evolving experience at a large tertiary referral centre 59
Psychological Prehabilitation Before Cancer Surgery: A Systematic Review 56
The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial 55
The Impact of Surgery on Survival of Patients With Cutaneous Melanoma Revisiting the Role of Primary Tumor Excision Margins 54
Pregnancy and melanoma: a European-wide survey to assess current management and a critical literature overview 54
Outcomes Following Extended Surgery for Retroperitoneal Sarcomas: Results From a UK Referral Centre 54
Should We Trust “Big Data” or “Meta-Data” to Guide Treatment for Patients with Resectable Esophageal Cancer? 53
null 51
Patterns of recurrence and survival after lymphadenectomy in melanoma patients: Clarifying the effects of timing of surgery and lymph node tumor burden 50
Standard or networked meta-analyses in assessing the best option for neo-adjuvant therapy in resectable oesophageal cancer: Chemotherapy or chemo-radiotherapy? 48
Retroperitoneal Liposarcoma: An Aggressive Strategy to Maximize Disease Control 44
Resectable extra-pleural and extra-meningeal solitary fibrous tumours: A multi-centre prognostic study 44
Selinexor versus doxorubicin in dedifferentiated liposarcoma PDXs: evidence of greater activity and apoptotic response dependent on p53 nuclear accumulation and survivin down-regulation 33
Neoadjuvant treatment: A novel standard? 27
Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG) 21
Hypnosis as sole anaesthesia for skin tumour removal in a patient with multiple chemical sensitivity. 19
Proximal and classic epithelioid sarcomas are distinct molecular entities defined by MYC/GATA3 and SOX17/endothelial markers, respectively 4
Totale 7.085
Categoria #
all - tutte 23.803
article - articoli 23.301
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 246
Totale 47.350


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.142 0 0 0 0 181 139 154 199 181 134 106 48
2020/2021911 47 55 37 106 34 95 63 84 138 90 94 68
2021/20221.255 37 141 178 96 44 44 84 132 56 30 120 293
2022/2023762 168 90 22 87 121 94 3 45 81 10 26 15
2023/2024550 22 55 61 37 29 62 44 45 28 48 63 56
2024/2025468 24 109 61 71 203 0 0 0 0 0 0 0
Totale 7.085